The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile


      Aims: Nitric oxide (NO) plays a protective role during atherogenesis. In the endothelium, NO is synthesised by the constitutive NO synthase (ecNOS). We analysed the relation of the ecNOS Glu298Asp and 4a/b gene polymorphisms to coronary artery disease (CAD) and myocardial infarction (MI) in a population of 3250 German subjects (533 healthy controls and 2717 individuals who underwent coronary angiography). Results: Although in the total sample, the ecNOS T allele was not associated with the risk of CAD (P=0.054) and the extent of this disease (P=0.078), a restriction to younger individuals (age≤61, mean age) revealed an association of the ecNOS T allele with an increased risk of CAD (1.43, 1.05–1.96; P=0.025) and with the severity of this disease (P=0.037). Similar observations were made in various high-risk populations. These associations were even more pronounced when the high-risk subgroups were restricted to younger individuals. For example, an odds ratio of 7.66 for CAD (95% CI, 2.0–29; P=0.003) was detected in diabetic individuals who were younger than 61 years. Also with respect to MI, the most pronounced associations of the ecNOS T allele with the risk of this disease were detected in younger individuals with at least one other cardiovascular risk factor. For example, in diabetics younger than 61 years, the relative risk for ecNOS T allele carriers was 9.73 (95% CI, 1.8–53; P=0.008). In contrast, the allele frequencies of the ecNOS 4a/b gene variation were essentially the same in controls and in CAD and MI patients. Conclusion: The present data extends earlier observations by the findings that predominantly younger T allele carriers of the ecNOS Glu298Asp gene polymorphism with various coronary high-risk profiles had an increased risk to suffer CAD and/or MI. In contrast, no evidence was found for an association of the ecNOS 4a/b gene polymorphism with coronary heart disease.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Moncada S.
        • Higgs A.
        The l-arginine–nitric oxide pathway.
        New Engl. J. Med. 1993; 329: 2002-2012
        • Kugiyama K.
        • Yasue H.
        • Okumura K.
        • Ogawa H.
        • Fujimoto K.
        • Nakao K.
        • Yoshimura M.
        • Moroyama T.
        • Inobe Y.
        • Kawano H.
        Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina.
        Circulation. 1996; 94: 266-272
        • Garg U.C.
        • Hassid A.
        Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.
        J. Clin. Invest. 1989; 83: 1774-1777
        • Furlong B.
        • Henderson A.H.
        • Lewis M.I.
        • Smith J.A.
        Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
        Br. J. Pharmacol. 1987; 90: 687-692
        • Yao S.-K.
        • Ober J.C.
        • Krisnaswami A.
        • Ferguson J.J.
        • Anderson V.
        • Golino P.
        • Buja L.M.
        • Willeron J.T.
        Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
        Circulation. 1992; 86: 1302-1309
        • Radomski M.W.
        • Palmer R.M.J.
        • Moncada S.
        Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.
        Lancet. 1987; 2: 1057-1058
        • Loscalzo J.
        • Welch G.
        Nitric oxide and it's role in the cardiovascular system.
        Prog. Cardiovasc. Dis. 1995; 38: 87-104
        • Kubes P.
        • Suzuki M.
        • Granger D.N.
        Nitric oxide: an endogenous modulator of leukocyte adhesion.
        Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 4651-4655
        • Lefer A.M.
        Nitric oxide: nature's naturally occurring leukocyte inhibitor.
        Circulation. 1997; 95: 553-554
        • Hingorani A.D.
        • Jia H.
        • Stevens P.A.
        • Stevens P.A.
        • Monteith P.S.
        • Brown M.J.
        A common variant in exon 7 of the endothelial constitutive nitric oxide synthase gene.
        Clin. Sci. 1995; 88: 21P
        • Yoshimura M.
        • Yasue H.
        • Nakayama M.
        • Shimasaki Y.
        • Sumida H.
        • Sugiyama S.
        • Kugiyama K.
        • Ogawa H.
        • Orgawa Y.
        • Saito Y.
        • Miyamoto Y.
        • Nakao K.
        A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese.
        Hum. Genet. 1998; 103: 65-69
        • Shimasaki Y.
        • Yasue H.
        • Yoshimura M.
        • Nakayama M.
        • Kugiyama K.
        • Ogawa H.
        • Harada E.
        • Masuda T.
        • Koyama W.
        • Saito Y.
        • Miyamoto Y.
        • Ogawa Y.
        • Nakao K.
        Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction.
        J. Am. Coll. Cardiol. 1998; 31: 1506-1510
        • Hibi K.
        • Ishigami T.
        • Tamura K.
        • Mizushima S.
        • Nyui N.
        • Fujita T.
        • Ochiai H.
        • Kosuge M.
        • Watanabe Y.
        • Yoshii Y.
        • Kihara M.
        • Kimura K.
        • Ishii M.
        • Umemura S.
        Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction.
        Hypertension. 1998; 32: 521-526
        • Hingorani A.D.
        • Liang C.F.
        • Fatibene J.
        • Lyon A.
        • Monteith S.
        • Parsons A.
        • Haydock S.
        • Hopper R.V.
        • Stephens N.G.
        • O'Shaughnessy K.
        • Brown M.J.
        A common variant of the endothelial nitric oxide synthase/Glu298(Asp) is a major risk factor for coronary artery disease in the UK.
        Circulation. 1999; 100: 1515-1520
        • Liyou N.
        • Simons L.
        • Friedlander Y.
        • Simons J.
        • McCallum J.
        • O'Shaughnessy K.
        • Johnson A.
        Coronary artery disease is not associated with the E298D variant of the constitutive, endothelial nitric oxide synthase gene.
        Clin. Genet. 1998; 54: 528-529
        • Cai H.
        • Wilcken D.E.L.
        • Wang X.L.
        The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease.
        J. Mol. Med. 1999; 77: 511-514
        • Wang X.L.
        • Sim A.S.
        • Badenhop R.F.
        • Mc Credie R.M.
        • Wilcken D.E.L.
        A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene.
        Nat. Med. 1996; 2: 41-45
        • Marsden P.A.
        • Heng H.H.
        • Scherer S.W.
        • Stewart R.J.
        • Hall A.V.
        • Shi X.M.
        • Tsui L.C.
        • Schappert K.T.
        Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.
        J. Biol. Chem. 1993; 268: 17478-17488
        • Nadaud S.
        • Bonnardeaux A.
        • Lathrop M.
        • Soubrier F.
        Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene.
        Biochem. Biophys. Res. Commun. 1994; 198: 1027-1033
      1. Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998; 83–86.

        • Sigusch H.H.
        • Surber R.
        • Lehmann M.H.
        • Surber S.
        • Weber J.
        • Henke A.
        • Reinhardt D.
        • Hoffmann A.
        • Figulla H.R.
        Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease.
        Scand. J. Clin. Lab. Invest. 2000; 60: 229-236
        • Odawara M.
        • Sasaki K.
        • Tachi Y.
        • Yamashita K.
        Endothelial nitric oxide gene polymorphism and coronary heart disease in Japanese NIDDM.
        Diabetologia. 1998; 41: 365-367
        • Rose D.A.
        The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.
        Bull. WHO. 1962; 27: 645-648
        • Gardemann A.
        • Schwartz O.
        • Haberbosch W.
        • Katz N.
        • Weiß T.
        • Tillmanns G.
        • Hehrlein F.W.
        • Waas W.
        • Eberbach A.
        Positive association of the β fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
        Thromb. Haemost. 1997; 77: 1120-1126
        • Gardemann A.
        • Fink M.
        • Stricker J.
        • Nguyen Q.
        • Humme J.
        • Katz N.
        • Tillmanns H.
        • Hehrlein F.W.
        • Rau M.
        • Haberbosch W.
        ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals.
        Atherosclerosis. 1998; 139: 153-159
        • Santoso S.
        • Kunicki T.J.
        • Kroll H.
        • Haberbosch W.
        • Gardemann A.
        Association of the platelet glycoprotein Ia C807T gene polymorphism with myocardial infarction in younger patients.
        Blood. 1999; 93: 2449-2453
        • Umbach D.M.
        • Weinberg C.R.
        Designing and analysing case–control studies to exploit independence of genotype and exposure.
        Stat. Med. 1997; 16: 1731-1743
        • Gardemann A.
        • Weidemann H.
        • Philipp M.
        • Katz N.
        • Tillmanns H.
        • Hehrlein F.W.
        • Haberbosch W.
        The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in high risk patients.
        Eur. Heart J. 1999; 20: 584-592
        • Miyahara K.
        • Kawamoto T.
        • Sase K.
        • Yui Y.
        • Toda K.
        • Yang L.X.
        • Hattori R.
        • Aoyama T.
        • Yamamoto Y.
        Cloning and structural characterization of the human endothelial nitric-oxide–synthase gene.
        Eur. J. Biochem. 1994; 223: 716-726
        • Philip I.
        • Plantefeve G.
        • Vuillaumier-Barrot S.
        • Vicaut E.
        • LeMarie C.
        • Henrion D.
        • Poirier O.
        • Levy B.I.
        • Desmonts J.M.
        • Durand G.
        • Bennessiano J.
        G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine.
        Circulation. 1999; 99: 3096-3098
        • Dohi Y.
        • Thiel M.A.
        • Bühler F.R.
        • Lüscher T.F.
        Activation of endothelial l-arginine pathway in resistance arteries: effect of age and hypertension.
        Hypertension. 1990; 16: 170-179
        • Yoon Y.
        • Song J.
        • Ho Hong S.
        • Kim J.Q.
        Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease.
        Clin. Chem. 2000; 46: 1626-1630
        • Tesauro M.
        • Thompson W.C.
        • Rogliani P.
        • Qi L.
        • Chaudhary P.P.
        • Moss J.
        Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.
        Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 2832-2835
        • Pulkkinen A.
        • Viitanen L.
        • Kareinen A.
        • Lehto S.
        • Vauhkonen I.
        • Laakso M.
        Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease.
        J. Mol. Med. 2000; 78: 372-379
        • Tsukada T.
        • Yokoyama K.
        • Arai T.
        • Takemoto F.
        • Hara S.
        • Yamada A.
        • Kawaguchi Y.
        • Hosoya T.
        • Igari J.
        Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans.
        Biochem. Biophys. Res. Commun. 1998; 245: 190-193